Portfolia

05/16/2026

~54% of postmenopausal U.S. women — more than 50 million people — have osteopenia, the precursor to osteoporosis. The majority of fragility fractures happen at this stage. Until OsteoBoost, the only options were pharmaceuticals typically prescribed after a fracture had already occurred.
This National Women’s Health Week, we’re spotlighting OsteoBoost — the first and only FDA-cleared prescription medical device for low bone density, named to TIME’s Best Inventions 2025. The wearable belt delivers calibrated low-intensity vibration to the lumbar spine and hips. In an NIH-funded, double-blinded, sham-controlled trial at the University of Nebraska Medical Center: 85% reduction in spine bone density loss, 83% reduction in spine bone strength loss, 55% reduction in hip bone density loss vs. sham.
Since its May 2025 nationwide launch, 2,500+ unique physicians across 30+ academic medical centers have prescribed it.

05/15/2026

60 million peri- and post-menopausal women in the U.S. Over 1 billion women globally projected to be in menopause by 2025. More than half experience vaginal dryness — historically addressable only through hormone therapy or in-office laser procedures costing thousands.
Joylux built a third option. This National Women’s Health Week, we’re spotlighting vFit — the at-home, hormone-free, red-light intimate wellness device co-designed by founder Colette Courtion and OB/GYN Dr. Sarah de la Torre. 1,000+ medical professionals recommend it. 90%+ of users report results. Halle Berry’s Respin partnered with Joylux in September 2024, and distribution now spans Nordstrom, Bloomingdale’s, Ulta, Neiman Marcus, Goop, and Amazon — with global expansion underway via Essity.
Menopause care is moving from clinic to home. Joylux is building the platform.
.

05/14/2026

National Women’s Health Week feels like the perfect moment to welcome Elizabeth Reede as one of our newest members of the Portfolia community—investing in both Women’s Health Fund IV and Rising America III alongside a global network of women backing the future of health, innovation, and impact.
Elizabeth brings a rare interdisciplinary perspective to the future of healthcare. She’s built her career at the intersection of finance, art, and technology—spanning roles as an investment banker, museum curator at the Museum of Modern Art, immersive tech founder, and now AI health entrepreneur.
As Co-Founder & CEO of E Squared Health, she’s building an AI-powered precision health platform designed to integrate lived experience with cross-system data—empowering women with more clarity, autonomy, and proactive control over their health journeys.
See who else has recently joined and learn more about this powerful community of women investors:
https://info.portfolia.com/-new-portfolia-members
Learn more about how Portfolia is celebrating National Women’s Health Week:
https://info.portfolia.com/portfolia-national-womens-health-week-2026

05/14/2026

In 2017, the wearable breast pump category did not exist. Willow shipped the world’s first all-in-one, in-bra pump at CES that year — quiet, app-connected, no tubes, no dangling bottles.
Eight years later, wearable pumps account for 57% of the entire U.S. breast pump market (Circana, 2024) — and in March 2025, Willow acquired Elvie, the global #2, to become the category consolidator. The combined entity is projected to deliver ~50% YoY revenue growth, with an expanded platform spanning pumps, pelvic-floor health (Trainer), and infant sleep (Rise).
When products are designed for women — not redesigned from products built for men — adoption is structurally faster. CEO Kate Ryder is proving it.

05/13/2026

$2.9B post-acquisition valuation. 20M+ users across the U.S., Canada, and Puerto Rico. ~$1.2B in lifetime sales — among the highest commercial pe*******on ever achieved by a D2C health brand.
This National Women’s Health Week, meet Everly Health (Everlywell), founded by Julia Cheek on a simple insight: lab tests are core healthcare infrastructure, and they should be consumer-grade. Today, Everly’s at-home test kits sell through CVS, Target, and direct-to-consumer, spanning fertility, thyroid, metabolism, and 30+ other panels.
Portfolia backed both U.S. unicorns in women’s health. No other firm has both.

05/12/2026

1 in 12 U.S. pregnancies are affected by preeclampsia — a leading cause of maternal mortality, with rates that have nearly doubled in the last decade. Until 2025, there was no way to predict it before symptoms appeared.
Now there is. This National Women’s Health Week, we’re spotlighting Mirvie. Their Encompass™ test — the first commercially available RNA-based blood test for personalized preeclampsia risk — launched in May 2025 with 91% sensitivity for preterm preeclampsia and a 99.7% negative predictive value, validated in 9,000+ pregnancies and published in Nature Communications.
An entirely new diagnostic category. Backed by Decheng, BlackRock, GV, Khosla, Mayfield, and the Gates Foundation.

02/14/2026

Link in bio 🔗 Heart disease is the #1 killer of women — yet for decades, women’s hearts were studied less, funded less, and too often misunderstood. That has real consequences.

On February 26, hear from the leaders driving meaningful innovations in women’s heart health — and the investors backing them: https://luma.com/heart-health

Our 2,000+ investors, primarily women, are changing the trajectory — backing 46 women’s health companies across 100+ investments as the most active investors in women’s health globally.

11/07/2025

Check the link in our bio to register. Did you know that you can use your IRA dollars to fuel innovation in women’s health?

03/15/2024

Friends, your health is compromised because 95% of investors are men. Learn about new health innovations and how to invest in them at the Portfolia Health Symposium March 21st 3pm in South San Francisco https://info.portfolia.com/women-health-symposium

Portfolia is the most active community of women investors in the world, with over 2,000 investors. We are the largest investor in women’s health with 40+ investments including Willow Pump L-Nutra Maven Clinic Everlywell Nola Masterson

Women's Health Symposium

10/17/2023

A little glance of what has happened last week on - we sum it up: “put your $ into solutions you want in the world”